6 results found.

Bronchiolitis Obliterans, Chronic Graft Versus Host Disease, Leuk Clinical Trial using Montelukast sodium; Flow cytometry; Laboratory biomarker analysis; Quality-of-life assessment

National Institutes of Health Clinical Center (CC) - Recruiting 6 years to 80 years.
- Multi-Institutional Prospective Phase II Study of Montelukast for the Treatment of Bronchiolitis Obliterans Following Allogeneic or Autologous Stem Cell Transplantation in Children and Adults.
Montelukast sodium; Flow cytometry; Laboratory biomarker analysis; Quality-of-life assessment

Bronchiolitis Obliterans, or Graft vs Host Disease Clinical Trial using Cyclosporine Inhalation Solution

National Institutes of Health Clinical Center (CC) - Recruiting 10 years to 80 years.
- Phase II Trial of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for Treatment of Bronchiolitis Obliterans.
Cyclosporine Inhalation Solution

Complication of Transplanted Lung Clinical Trial using Aztreonam Lysine for Inhalation (AZLI); Status Post Lung Transplant

Duke University - Recruiting 18 years or older.
- Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS) After Lung Transplantation.
Aztreonam Lysine for Inhalation (AZLI); Status Post Lung Transplant

Bronchiolitis Obliterans, Constructive Bronchiolitis, or Graft Ve Clinical Trial using Inhaled Cyclosporine Solution

National Institutes of Health Clinical Center (CC) - Recruiting 10 years to 80 years.
- Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans.
Inhaled Cyclosporine Solution

Lung Transplant, Bronchiolitis Obliterans, or Obliterative Bronch Clinical Trial

National Institute of Allergy and Infectious Diseases (NIAID) - Recruiting N/A to 21 years.
- Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation (CTOTC-03).

Respiratory Tract Infections, Bronchiolitis Obliterans, Cryptogen Clinical Trial using Prednisone; Azithromycin; Montelukast; Symbicort

Maisonneuve-Rosemont Hospital - Recruiting 18 years or older.
- Does Increasing Immunosuppression Prevent Transplant-associated Lung-disease Triggered by Viral Respiratory Tract Infection Following Allogeneic Stem Cell Transplant? A Pilot Study.
Prednisone; Azithromycin; Montelukast; Symbicort